SpectraCure AB - Asset Resilience Ratio

Latest as of December 2025: 12.95%

SpectraCure AB (SPEC) has an Asset Resilience Ratio of 12.95% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check SpectraCure AB (SPEC) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

Skr13.53 Million

≈ $1.46 Million USD Cash + Short-term Investments

Total Assets

Skr104.47 Million

≈ $11.24 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how SpectraCure AB's Asset Resilience Ratio has changed over time. See how leveraged is SpectraCure AB's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down SpectraCure AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SpectraCure AB market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr13.53 Million	12.95%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr13.53 Million	12.95%

Asset Resilience Insights

Moderate Liquidity: SpectraCure AB has 12.95% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

SpectraCure AB Industry Peers by Asset Resilience Ratio

Compare SpectraCure AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%

Annual Asset Resilience Ratio for SpectraCure AB (2016–2025)

The table below shows the annual Asset Resilience Ratio data for SpectraCure AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.95%	Skr13.53 Million ≈ $1.46 Million	Skr104.47 Million ≈ $11.24 Million	-2.16pp
2024-12-31	15.10%	Skr18.27 Million ≈ $1.97 Million	Skr121.00 Million ≈ $13.02 Million	-24.22pp
2023-12-31	39.32%	Skr56.95 Million ≈ $6.13 Million	Skr144.83 Million ≈ $15.59 Million	-18.05pp
2022-12-31	57.37%	Skr93.18 Million ≈ $10.03 Million	Skr162.42 Million ≈ $17.48 Million	-10.70pp
2021-12-31	68.07%	Skr129.69 Million ≈ $13.96 Million	Skr190.52 Million ≈ $20.50 Million	-6.61pp
2020-12-31	74.69%	Skr157.24 Million ≈ $16.92 Million	Skr210.53 Million ≈ $22.66 Million	+20.58pp
2019-12-31	54.10%	Skr54.21 Million ≈ $5.83 Million	Skr100.19 Million ≈ $10.78 Million	-11.27pp
2018-12-31	65.38%	Skr45.08 Million ≈ $4.85 Million	Skr68.95 Million ≈ $7.42 Million	+48.79pp
2017-12-31	16.59%	Skr2.44 Million ≈ $262.60K	Skr14.71 Million ≈ $1.58 Million	+15.26pp
2016-12-31	1.33%	Skr381.67K ≈ $41.07K	Skr28.77 Million ≈ $3.10 Million	--

pp = percentage points

About SpectraCure AB

ST:SPEC Sweden Medical Devices

Market Cap

$2.18 Million

Skr20.28 Million SEK

Market Cap Rank

#29876 Global

#691 in Sweden

Share Price

Skr0.05

Change (1 day)

+5.32%

52-Week Range

Skr0.05 - Skr0.31

All Time High

Skr43.59